Literature DB >> 21292558

Electroencephalographic and seizure manifestations of pyridoxal 5'-phosphate-dependent epilepsy.

Aravindhan Veerapandiyan1, Sara A Winchester, William B Gallentine, Edward C Smith, Sujay Kansagra, Keith Hyland, Mohamad A Mikati.   

Abstract

We describe the electroencephalographic and clinical seizure manifestations of pyridoxal 5'-phosphate-dependent epilepsy (PLP-DE) in two patients [diagnosis confirmed by low cerebrospinal fluid (CSF) PLP, complete resolution of previously intractable seizures with PLP supplementation, negative pyridoxine-dependent epilepsy CSF biomarkers, and/or positive disease causing pyridox(am)ine 5'-phosphate oxidase gene mutation] along with a comprehensive review of the literature. One patient presented with neonatal tonic status epilepticus with subsequent generalized tonic-clonic seizures, and the second, with refractory complex partial seizures starting at 2 years of age. The pretreatment EEG revealed, interictally, burst suppression, multifocal independent sharp waves, and electrical status epilepticus in sleep. Ictally and interictally, it revealed runs of unilateral spike/slow waves. Previously reported features include burst suppression, myoclonus, tonic seizures, clonic seizures, and spasms. In the appropriate clinical scenario, the aforementioned features should raise the possibility of PLP-DE and appropriate treatment should be initiated. The first late-onset case (at 2 years) of PLP-DE is reported.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21292558     DOI: 10.1016/j.yebeh.2010.12.046

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  10 in total

1.  Novel phenotypes of pyridox(am)ine-5'-phosphate oxidase deficiency and high prevalence of c.445_448del mutation in Chinese patients.

Authors:  Jiao Xue; Xingzhi Chang; Yuehua Zhang; Zhixian Yang
Journal:  Metab Brain Dis       Date:  2017-03-27       Impact factor: 3.584

Review 2.  Clinical review of genetic epileptic encephalopathies.

Authors:  Grace J Noh; Y Jane Tavyev Asher; John M Graham
Journal:  Eur J Med Genet       Date:  2012-01-25       Impact factor: 2.708

3.  PNPO Deficiency and Cirrhosis: Expanding the Clinical Phenotype?

Authors:  D Coman; P Lewindon; P Clayton; K Riney
Journal:  JIMD Rep       Date:  2015-06-25

4.  Normal Cerebrospinal Fluid Pyridoxal 5'-Phosphate Level in a PNPO-Deficient Patient with Neonatal-Onset Epileptic Encephalopathy.

Authors:  Alina Levtova; Stephane Camuzeaux; Anne-Marie Laberge; Pierre Allard; Catherine Brunel-Guitton; Paola Diadori; Elsa Rossignol; Keith Hyland; Peter T Clayton; Philippa B Mills; Grant A Mitchell
Journal:  JIMD Rep       Date:  2015-03-12

5.  Pyridoxine responsiveness in novel mutations of the PNPO gene.

Authors:  Barbara Plecko; Karl Paul; Philippa Mills; Peter Clayton; Eduard Paschke; Oliver Maier; Oswald Hasselmann; Gudrun Schmiedel; Simone Kanz; Mary Connolly; Nicole Wolf; Eduard Struys; Sylvia Stockler; Lucia Abela; Doris Hofer
Journal:  Neurology       Date:  2014-03-21       Impact factor: 9.910

6.  Normal Neurodevelopmental Outcomes in PNPO Deficiency: A Case Series and Literature Review.

Authors:  J Hatch; D Coman; P Clayton; P Mills; S Calvert; R I Webster; Kate Riney
Journal:  JIMD Rep       Date:  2015-08-25

7.  Pyridoxine responsive epilepsy caused by a novel homozygous PNPO mutation.

Authors:  B Jaeger; N G Abeling; G S Salomons; E A Struys; M Simas-Mendes; V G Geukers; B T Poll-The
Journal:  Mol Genet Metab Rep       Date:  2016-02-10

Review 8.  Phenotypic and molecular spectrum of pyridoxamine-5'-phosphate oxidase deficiency: A scoping review of 87 cases of pyridoxamine-5'-phosphate oxidase deficiency.

Authors:  Malak Alghamdi; Fahad A Bashiri; Marwa Abdelhakim; Nouran Adly; Dima Z Jamjoom; Khalid M Sumaily; Bandar Alghanem; Stefan T Arold
Journal:  Clin Genet       Date:  2020-09-16       Impact factor: 4.438

9.  Epilepsy due to PNPO mutations: genotype, environment and treatment affect presentation and outcome.

Authors:  Philippa B Mills; Stephane S M Camuzeaux; Emma J Footitt; Kevin A Mills; Paul Gissen; Laura Fisher; Krishna B Das; Sophia M Varadkar; Sameer Zuberi; Robert McWilliam; Tommy Stödberg; Barbara Plecko; Matthias R Baumgartner; Oliver Maier; Sophie Calvert; Kate Riney; Nicole I Wolf; John H Livingston; Pronab Bala; Chantal F Morel; François Feillet; Francesco Raimondi; Ennio Del Giudice; W Kling Chong; Matthew Pitt; Peter T Clayton
Journal:  Brain       Date:  2014-03-18       Impact factor: 13.501

10.  Molecular characterization of pyridoxine 5'-phosphate oxidase and its pathogenic forms associated with neonatal epileptic encephalopathy.

Authors:  Anna Barile; Isabel Nogués; Martino L di Salvo; Victoria Bunik; Roberto Contestabile; Angela Tramonti
Journal:  Sci Rep       Date:  2020-08-12       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.